Global Stem Cell Umbilical Cord Blood (UCB) Market 2015-2019

Category : Diagnostic and Biotech  | Published Date : Aug-2015 | Pages : 82
About Stem Cell UCB
UCB is the blood that remains in the placenta and the attached umbilical cord after childbirth. UCB contains stem cells that are unique, smart, and are capable of treating several life-threatening diseases. They are used in the treatment of hematopoietic and genetic disorders. The placental blood can produce 10 times more quantity of stem cells compared to the umbilical cord, which can in turn be used for the treatment of an adult patient. The cord blood that is collected during the childbirth is stored and cryopreserved. The storage of the cord blood can be done at private cord blood banks or public cord blood banks. This preserved blood can be used for the transplantation, and treatment of diseases at the later stages of life.

Technavios analysts forecast the global stem cell UCB market to grow at a CAGR of 30.36% over the period 2014-2019.

Covered in this Report
The report covers the present scenario and the growth prospects of the global stem cell UCB market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the banking and utilization of UCB stem cells for the treatment of various disorders, such as cancers, blood disorders, metabolic disorders, immune diseases, and others.

Technavios report, Global Stem Cell UCB Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global stem cell UCB market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
• Americas

Key Vendors
• Caladrius Biosciences 
• Celgene 
• Mesoblast 
• Pluristem Therapeutics

Other Prominent Vendors
• Athersys
• CHA Bio and Diostech 
• Cytori Therapeutics
• Nuo Therapeutics 
• Ocata Therapeutics 
• Opexa Therapeutics 
• Osiris Therapeutics 
• Teva Pharmaceuticals 
• United Therapeutics 

Key Market Driver
• Effective Treatment of Life-threatening Diseases
• For a full, detailed list, view our report

Key Market Challenge
• Stringent Regulations
• For a full, detailed list, view our report

Key Market Trend
• Growing Public Awareness
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Process of Collection, Processing and Storage of Cord Blood Cells

06.1 Donor Evaluation

06.2 Collection Methods

06.3 Processing and Storage Methods

06.4 Sample Retention and Length of Storage

07. Facts: Cord Blood Units

08. US FDA Approved Stem Cell UCB Product

08.1 Hemacord

08.1.1 Mechanism of Action

08.1.2 Side Effects

09. Pipeline Analysis

09.1 Information on the Pipeline Candidates

09.1.1 PDA-002

09.1.2 PDA-001

09.1.3 PLX-PAD

09.1.4 PLX-R18

10. Market Landscape

10.1 Market Overview

10.2 Market Size and Forecast

10.3 Five Forces Analysis

11. Market Segmentation by Application

11.1 Cancers

11.2 Blood Disorders

11.3 Metabolic Disorders

11.4 Immune Disorders

11.5 Others

12. Market Segmentation by Storage

12.1 Public Cord Blood Bank

12.2 Private Cord Blood Bank

12.3 Public-Private Cord Blood Banks

13. Harmonization of Biobanking

14. Market Segmentation by End-users

14.1 Research Institutes

14.2 Pharmaceutical Companies

14.3 Biobanks

14.4 Hospitals

15. Geographical Segmentation

15.1 Stem Cell UCB Market in Americas

15.1.1 Market Size and Forecast

15.2 Stem Cell UCB Market in EMEA

15.2.1 Market Size and Forecast

15.3 Stem Cell UCB Market in APAC

15.3.1 Market Size and Forecast

16. Buying Criteria

17. Market Growth Drivers

18. Drivers and their Impact

19. Market Challenges

20. Impact of Drivers and Challenges

21. Market Trends

22. Trends and their Impact

23. Vendor Landscape

23.1 Competitive Scenario

23.1.1 Key News

23.1.2 Mergers and Acquisitions

23.2 Market Share Analysis 2014

23.2.1 Caladrius Biosciences

23.2.2 Celgene

23.2.3 Mesoblast

23.2.4 Pluristem Therapeutics

23.3 Other and Future Prominent Vendors

24. Global Stem Cell UCB Market: Key Takeaways

25. Key Vendor Analysis

25.1 Caladrious

25.1.1 Key Facts

25.1.2 Business Overview

25.1.3 Business Segmentation by Revenue 2014

25.1.4 Business Segmentation by Revenue 2013 and 2014

25.1.5 Geographical Segmentation by Revenue 2014

25.1.6 Business Strategy

25.1.7 Recent Developments

25.1.8 SWOT Analysis

25.2 Celgene

25.2.1 Key Facts

25.2.2 Business Overview

25.2.3 Business Strategy

25.2.4 Business Segmentation by Revenue

25.2.5 Sales by Geography

25.2.6 Key Information

25.2.7 SWOT Analysis

25.3 Mesoblast

25.3.1 Key Facts

25.3.2 Business Overview

25.3.3 Therapeutic Areas

25.3.4 Geographical Segmentation

25.3.5 Business Strategy

25.3.6 Recent Developments

25.3.7 SWOT Analysis

25.4 Pluristem

25.4.1 Key Facts

25.4.2 Business Overview

25.4.3 Geographical Presence

25.4.4 Business Strategy

25.4.5 Recent Developments

25.4.6 SWOT Analysis

26. Other Reports in this Series

List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Donor Evaluation Before Collection of Cord Blood Cells
Exhibit 3: Collection of Cord Blood Cells
Exhibit 4: Processing and Storage Methods of Cord Blood Cells
Exhibit 5: Stem Cell Transplantations by Patients Race in US
Exhibit 6: Pipeline Portfolio of Stem Cell UCB Products for Different Diseases
Exhibit 7: Global Stem Cell UCB Market 2014-2019 ($ millions)
Exhibit 8: Global Stem Cell UCB Market Segment by Application
Exhibit 9: Global Stem Cell UCB Market Segment by Storage
Exhibit 10: Organizations and Initiatives Toward Biobank Harmonization
Exhibit 11: Key Factors Involved in Harmonization of Biobanks
Exhibit 12: Key Focus Areas in Harmonization of Biobanks
Exhibit 13: Organizations and Initiatives in Harmonizing Science and Infrastructure
Exhibit 14: Initiatives on Biobanking Resource Tools and Databases
Exhibit 15: Global Stem Cell UCB Market Segment by End-users
Exhibit 16: Segmentation of Global Stem Cell UCB Market by Geography 2014
Exhibit 17: Stem Cell UCB Market in Americas 2014-2019 ($ millions)
Exhibit 18: Stem Cell UCB Market in APAC 2014-2019 ($ millions)
Exhibit 19: Stem Cell UCB Market in APAC 2014-2019 ($ millions)
Exhibit 20: Statistics of Stem Cell UCB Market : By Geography
Exhibit 21: Global Stem Cell UCB Market: Key Takeaways
Exhibit 22: Caladrious: Business Segmentation by Revenue 2014
Exhibit 23: Caladrious: Business Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 24: Caladrious: Geographical Segmentation by Revenue 2014
Exhibit 25: Celgene: Business Segmentation by Revenue 2011-2013 ($ millions)
Exhibit 26: Celgene: Sales by Geography 2013
Exhibit 27: Mesoblast: Therapeutic Areas
Exhibit 28: Mesoblast: Geographical Segmentation
Exhibit 29: PLuristem: Geographical Presence
Publisher Name : Technavio


Please Select Format
Single User: US $ 2500
Five User: US $ 3000
Site User: US $ 4000
Global User: US $ 10000

market research offer
Contact us
Call us +1-971-202-1575
--- or ---
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.